ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 24 filers reported holding ZOSANO PHARMA CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $27,000 | -20.6% | 118,962 | +61.1% | 0.00% | – |
| Q4 2021 | $34,000 | +25.9% | 73,853 | +98.1% | 0.00% | – |
| Q3 2021 | $27,000 | -22.9% | 37,282 | 0.0% | 0.00% | – |
| Q2 2021 | $35,000 | -38.6% | 37,282 | -18.7% | 0.00% | – |
| Q1 2021 | $57,000 | +2750.0% | 45,879 | +954.9% | 0.00% | – |
| Q4 2020 | $2,000 | -99.9% | 4,349 | -99.7% | 0.00% | – |
| Q3 2020 | $2,052,000 | +22700.0% | 1,266,303 | +12157.3% | 0.00% | – |
| Q2 2020 | $9,000 | +28.6% | 10,331 | -11.6% | 0.00% | – |
| Q1 2020 | $7,000 | -50.0% | 11,685 | +29.8% | 0.00% | – |
| Q4 2019 | $14,000 | -98.9% | 9,000 | -96.7% | 0.00% | – |
| Q1 2019 | $1,282,000 | +210.4% | 268,761 | +37.9% | 0.00% | – |
| Q4 2018 | $413,000 | -48.2% | 194,880 | 0.0% | 0.00% | – |
| Q3 2018 | $797,000 | +17.2% | 194,880 | +16.9% | 0.00% | – |
| Q2 2018 | $680,000 | +389.2% | 166,690 | +502.4% | 0.00% | – |
| Q1 2018 | $139,000 | – | 27,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,600,000 | $7,632,000 | 5.81% |
| Telemetry Investments, L.L.C. | 242,826 | $1,158,000 | 0.59% |
| MYDA Advisors LLC | 72,000 | $343,000 | 0.17% |
| Highlander Capital Management, LLC | 10,000 | $48,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $4,770,000 | 0.01% |
| Hartford Financial Management Inc. | 2,000 | $10,000 | 0.00% |
| GABELLI FUNDS LLC | 21,297 | $102,000 | 0.00% |
| IFP Advisors, Inc | 1,248 | $6,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 81,829 | $390,000 | 0.00% |
| DEUTSCHE BANK AG\ | 100 | $0 | 0.00% |